About
A growth strategy consultant, neuroscientist, and innovation expert focused on scaling Life Sciences and HealthTech companies. She advises BioTech, MedTech, and healthcare organizations on strategic growth and commercialization.
Experience
- RocheHead of Diagnostics Strategycurrent2025 — present
- Privilège VenturesAdvisory Board Membercurrent2024 — present
- IQVIALead Neuroscience, Rare Diseases and Emerging Biopharma sectors, EMEA Consulting2024 — 2025Basel, Switzerland
- Monitor DeloittePartner, Life Sciences Strategy2022 — 2024
- Monitor DeloitteDirector, Life Sciences Strategy2016 — 2022
- Monitor DeloitteProject Manager, Life Sciences Strategy (Manager /Sr. Manager)2011 — 2016
- Monitor DeloitteConsultant / Sr. Consultant2007 — 2011
- Brain Research InstitutePostdoc Researcher / Grade Student2002 — 2007
- Lab for Behavioral & Cognitive NeurosciencesResearch Intern2000 — 2002
Education
- ETH ZürichPhD, Biology2002 — 2006
- Université Louis Pasteur (Strasbourg I)Master, Neurosciences2000 — 2002
Skills & more
Venture Capital1Board of Directors1Board GovernanceDigital HealthPharmaceuticsMedical TechnologyBiotechnologyStrategic PartnershipsStakeholder ManagementBiostatisticsBusiness TransformationProject Management
+12 more
Data AnalysisMarket ResearchResearch and Development (R&D)NeuroscienceBrand PlanningGo-to-Market StrategyCommercial Due DiligenceGrowth strategyHealth techCommercial TransformationStrategyValue Based Healthcare- High Performance Boards Program — IMD
From Elisabeth's professional profile.
Colleagues at Privilège Ventures
Alessandro Ragni
Associate at Privilège Ventures
Angelica Morrone
General Partner at Privilège Ventures
Cesare Pezzini
Investment Associate at Privilège Ventures
Didier Denat
Chairman of the Board at Privilège Ventures
Haena Kim
Venture Partner at Privilège Ventures
Jacqueline
Investor at Privilège Ventures
Jacqueline Ruedin Rüsch
Founding General Partner at Privilège Ventures
Lea Von Bidder
Venture Partner at Privilège Ventures
Frequently asked questions
- Where does Elisabeth Aloy work?
- Elisabeth Aloy is Advisor at Privilège Ventures.
Same school
Also attended ETH Zürich210
Bastian HasslingerInvestor at Index VenturesSteve VassalloInvestor at Foundation CapitalHelge DaebelPartner, Head of Water at Emerald Technology Ventures AgMaurin DaiInvestment Manager, Physical AI & Robotics at Emerald Technology Ventures AgChristoph FreiPartner, Head of Energy at Emerald Technology Ventures AgMax HeftiInvestment Director - Energy at Emerald Technology Ventures Ag
+ 204 more
Shared employers
Also worked at IQVIA31
Alain HuriezVenture Partner at Advent Life SciencesDana Marohn SpiliotisPartner at Operator CollectiveRoel DekkersInvestment manager at NoaberMaulik MehtaManaging Partner at Excelerate Health VenturesMartin GouldstoneDigital Pharma Advisor at Excelerate Health VenturesJeanne HechtDigital Pharma Advisor at Excelerate Health Ventures
+ 25 more
Also worked at Monitor Deloitte72
Erica WuInvestment Director at Intel CapitalCandice FaktorFounder, CEO, speaker, and investor focused on unlocking human potential in the age of AIParth DesaiPartner at Flare Capital PartnersAaron SamuelsInvestor, Entrepreneur, Artist, StorytellerAravind RatnamChief Strategy Office, Q-Ctrl at SeafundDave BoyceDirector at Mercato Partners
+ 66 more